Company intelligence / Profile preview

BIOMIR service

Krasnoznamensk, Moscow Oblast, Russia
Ownership
Private
Development stage
Other
01

Overview

BIOMIR Service is a Russian biotechnology company founded in 2000 that specializes in tissue engineering and regenerative medicine. The company develops and manufactures innovative biomimetic products, most notably the SpheroGEL heterogeneous implantable gel and the ElastoPOB biopolymer membrane, which are designed to mimic the extracellular matrix and stimulate natural tissue repair. These products are utilized across a wide range of clinical applications, including surgery, ophthalmology, and traumatology, to restore the morphological and functional properties of damaged tissues. BIOMIR Service operates in close collaboration with leading scientific institutions, such as the Shumakov National Medical Research Center of Transplantology and Artificial Organs, to advance the field of bioengineered cellular products.

Therapeutic areas
OtherNeurologyDermatologyGastroenterologyMen's HealthOphthalmology
Modalities
Hydrogel-based drug delivery therapyBiopolymerNanoparticleBiologic
Industry
Implantable Medical Devices
02

Partnerships

Institute of Biomedical Research and Technology (ANO IBRT)Shumakov National Medical Research Center of Transplantology and Artificial Organs

Beyond the preview

Go deeper on BIOMIR service.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BIOMIR service.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call